Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study

Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study

Abstract Background Dementia is a prevalent non-motor manifestation among individuals with advanced Parkinson’s disease (PD). Glial fibrillary acidic protein (GFAP) is an inflammatory marker derived from astrocytes. Research has demonstrated the potential of plasma GFAP to forecast the progression t...

Full description

Bibliographic Details
Main Authors: Tingting Liu, Hongzhou Zuo, Di Ma, Dan Song, Yuying Zhao, Oumei Cheng
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Neuroinflammation
Subjects:
Parkinson’s disease
Cerebrospinal fluid
Glial fibrillary acidic protein
Parkinson’s Progression Markers Initiative
Cognition decline
Online Access:https://doi.org/10.1186/s12974-023-02843-5

Internet

https://doi.org/10.1186/s12974-023-02843-5

Similar Items